There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and number of hypertension patients. These factors are primarily attributed to growth of Electrophysiology/Atrial Fibrillation market. The report ?Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022? provides an in-depth analysis of global electrophysiology/atrial fibrillation market.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global electrophysiology/atrial fibrillation ablation market. The report has been segmented as following:-
Market Segmentation
? By Products
? EP Ablation Catheters
? EP Diagnostic Catheters
? Cardiac Monitors
? By Application
? EP Monitoring Devices
? EP Treatment Devices
Key Vendors
? Medtronic Plc
? Biosense Webster, Inc.
? Abbott Laboratories
? Boston Scientific Corporation

Electrophysiology is the study of electrical system of the heart in order to determine best treatment option for cardiac arrhythmia. Some of the most common indications where EP is used are Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNR), Wolff-Parkinson-White Syndrome (WPW), among others. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia characterised by loss of the normal electrical rhythm of the heart. There are two main types of atrial fibrillation-Paroxysmal atrial fibrillation and Persistent or permanent atrial fibrillation. Based on unique needs of patient, cardiologist discusses symptoms with the patient and determine proper treatment based on unique needs of each patient.
Growth of global electrophysiology/atrial fibrillation ablation market is primarily attributed to factors such as higher prevalence of atrial fibrillation, rise in number of hypertension patients, increasing incidence of valvular heart diseases, growing geriatric population and increasing demand for minimally invasive procedure. However, the market faces challenges due to stringent regulatory approval, reimbursement issues, dearth of skilled professionals and treatment skewed towards pharmaceutical intervention. The market is characterized by leading trends such as FIRM-guided ablation for atrial fibrillation, rise in number of mergers and acquisitions and advent of New Oral Anticoagulants (NOACS).
The report ?Global Electrophysiology/Atrial Fibrillation Ablation Market Outlook 2022? provides in-depth analysis of the current scenario, detailed market outlook of the global electrophysiology/atrial fibrillation market with coverage on major market segments such as EP Products (EP Ablation Catheters, EP Diagnostic Catheters and Cardiac Monitors) and EP Applications (EP Monitoring Devices and EP Treatment Devices). Future forecasts of Electrophysiology market overall and across various sub-segments is provided in the report till the year 2022. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global electrophysiology/atrial fibrillation ablation market include Medtronic Plc, Biosense Webster, Inc., Abbott Laboratories, Boston Scientific Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global electrophysiology/atrial fibrillation ablation market.